本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Avalo Therapeutics Inc

16.12
-1.0600-6.17%
盤後16.120.00000.00%19:30 EDT
成交量:252.55萬
成交額:4,155.14萬
市值:8.65億
市盈率:-3.66
高:18.14
開:17.42
低:16.02
收:17.18
52周最高:24.27
52周最低:9.54
股本:5,363.00萬
流通股本:4,014.95萬
量比:3.39
換手率:6.29%
股息:- -
股息率:- -
每股收益(TTM):-4.4100
每股收益(LYR):-5.8400
淨資產收益率:-36.27%
總資產收益率:-18.50%
市淨率:1.93
市盈率(LYR):-2.76

資料載入中...

2026/07/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/23

重要事件披露

Form 8-K - Current report
2026/06/18

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/06/05

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/26

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report